JFJill Ferrari

Jill Ferrari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jill Ferrari has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Verrucae pedis in children with juvenile idiopathic arthritis and other paediatric rheumatic diseases: a cross‐sectional study

    by Jill Ferrari

    Background: Verrucae pedis (verrucae / VPs) are a common viral infection of the skin seen in children. There are limited studies of the prevalence, duration and impact of verrucae pedis in children who are immunosuppressed. The studies available suggest that, in these children, the warts are more widespread and are more long‐standing. The primary aim of this study was to determine the prevalence of verrucae pedis in children attending rheumatology clinics who may have some degree of immunosuppression due to their prescribed medication and compare this to the reported prevalence in the healthy population.Method: Children attending out‐patient rheumatology appointments were recruited. The young people were aged between four and 17 years old. A visual inspection of both feet was used to identify potential verrucae. Diagnosis of a verruca pedis was confirmed on observation of the typical clinical features. The location, duration of presence, previous treatments, presence of verrucae in other family members and psychological impact was recorded.Results: A total of 71 children were included. Of the group, 55 children had no verrucae present, 16 children had one or more verrucae. The prevalence of verrucae was 22.5%. Medication impacting on the immune system was prescribed in 80% of the group. There appeared to be no greater chance of having verrucae if taking immunosuppressive medication than compared to having no medication (OR = 1.1, 95%CI 0.26 to 4.48, p = 0.46). Children with verrucae tended to be between 9 and 12 years old. In total, 37.5% of the young people with verrucae had lesions reportedly present for 24 months or more. Two‐thirds of the participants were not concerned about verrucae being present and most participants with a verruca were not aware of what a verruca was, but despite this the majority of participants (81%) had sought treatment for the verrucae.Conclusion: Children with Juvenile Idiopathic Arthritis and other rheumatic conditions have no greater prevalence of verrucae compared to the general population. The verrucae present were of a similar clinical type and did not seem to be more widespread or have atypical features, which has been reported in other immunocompromised populations. The percentage of lesions remaining beyond 24 months was found to be slightly greater than has been reported in other healthy populations. The children in this study seemed to be less emotionally concerned about their verrucae, despite this most families had sought treatment for the verrucae.


  • Open Access

    Verrucae pedis in children with Juvenile Idiopathic Arthritis and other paediatric rheumatic diseases: a cross-sectional study.

    by Jill Ferrari

    Background Verrucae pedis (VPs) are a common viral infection of the skin seen in children. There are limited studies of the prevalence, duration and impact of VPs in children who are immunosuppressed. The studies available suggest that, in these children, the warts are more widespread and are more long-standing. The primary aim of this study was to determine the prevalence of VPs in children attending rheumatology clinics who may have some degree of immunosuppression due to their prescribed medication and compare this to the reported prevalence in the healthy population. Method Children attending out-patient rheumatology appointments who had a paediatric rheumatology consultant named as the lead clinician, were recruited. The young people were aged between four and 17 years old. A visual inspection of both feet was used to identify potential VPs. Diagnosis of a VP was confirmed on observation of the typical clinical features of a VP. The location, duration of presence, previous treatments, presence of VPs in other family members and psychological impact was recorded. Results A total of 71 children were included. Of the group, 55 children had no VPs present, 16 children had one or more VPs. The prevalence of VPs was 22.5%. Medication impacting on the immune system was prescribed in 80% of the group. There appeared to be no greater chance of having VPs if taking immunosuppressive medication than compared to having no medication (OR = 1.1, 95%CI 0.26 to 4.48, p = 0.46). Children with VPs tended to be 9 years old or older with few children in the older age range (13–17 yrs) having VPs suggesting that most VPs do resolve by the teenage years. In total, 37.5% of the young people with VPs had lesions that had been present for 24 months or more. Two-thirds of the subjects were not concerned about VPs being present and most subjects with a VP did not know what it was, but despite this the majority of subjects (81%) had sought treatment for the VPs. Conclusion Children with JIA and other rheumatic conditions have no greater prevalence of VPs compared to the general population. The VPs present were of a similar clinical type and did not seem to be more widespread or unusual as has been reported in other immunocompromised populations. The percentage of lesions remaining beyond 24 months was found to be slightly greater than has been reported in other healthy populations. The children in this study seemed to be less concerned psychologically about their VPs, despite this most families had sought treatment for the verrucae.

  • Open Access

    Patient perceptions of foot disability in Juvenile Idiopathic Arthritis: a comparison of the juvenile arthritis foot disability index and the Oxford ankle foot questionnaire for children

    by Jill Ferrari

    Background: The Juvenile Arthritis Foot Disability Index (JAFI) and the Oxford Ankle Foot Questionnaire for Children (OxAFQ‐C) are two region‐specific paediatric outcome tools that measure the impact on well‐being in children with foot pathology. The aim of this study was to establish the level of agreement between the JAFI and the OxAFQ‐C in a group of children diagnosed with Juvenile Idiopathic Arthritis (JIA).Methods: Children with JIA accessed the questionnaire via a website. The OxAFQ‐C questionnaire and the JAFI questionnaire were combined into one document consisting of 42 statements with Likert‐scale responses. A further question regarding duration of disease was added. On completion, the web‐linked questionnaire was returned by e‐mail.Results: Thirty five participants were included. Individual domain and composite score analysis was undertaken. The JAFI participation domain was compared to the OxAFQ‐C school domain and showed no significant difference between the median scores of each participant (z = ‐1.33, p = 0.181). The JAFI activity and the OxAFQ‐C physical domains were compared and showed that a significant difference between the median scores existed (z = ‐4.29, p < 0.001). Agreement between the two PROMs was tested using Bland Altman Levels of Agreement based upon the percentage summed composite scores. Levels of agreement between the scores were considered to be poor based on the Bland Altman plot, despite a low mean difference in scores (mean difference = ‐3.88, SD of difference = 9.93, p = 0.027). Pearson correlation was undertaken to measure the relationship between the summed composite score and disease duration. No relationship was found (JAFI: r = ‐0.08, p = 0.672; OxAFQ‐C: r = 0.037, p = 0.871).Conclusions: This study has shown that despite some agreement between the individual domains, overall there is poor agreement between the OxAFQ‐C and the JAFI percentage summed composite scores. The study is not able to determine if one score is superior to the other but both scores could be of value when used in this population.


  • Open Access

    Inter‐rater reliability of the Foot Posture Index (FPI‐6) in the assessment of the paediatric foot

    by Stewart C Morrison, Jill Ferrari

    Background: Reliability is an integral component of clinical assessment and necessary for establishing baseline data, monitoring treatment outcomes and providing robust research findings. In the podiatric literature traditional measures of foot assessment have been shown to be largely unreliable. The Foot Posture Index (FPI‐6) is a clinical tool used in the assessment of foot and to date, there is limited research published which evaluates the reliability of this tool in children and adolescents.Method: Thirty participants aged 5 ‐ 16 years were recruited for the research. Two raters independently recorded the FPI‐6 score for each participant.Results: Almost perfect agreement between the two raters was identified following weighted kappa analysis (Kw = 0.86).Conclusion: The FPI‐6 is a quick, simple and reliable clinical tool which has demonstrated excellent inter‐rater reliability when used in the assessment of the paediatric foot.


  • Foot Pressure Measurement Differences Between Boys and Girls With Reference to Hallux Valgus Deformity and Hypermobility

    by Jill Ferrari, David Watkinson

    Background: Previous studies that compared foot pressures in boys and girls found that girls had greater peak pressures under the hallux than did boys. Only one of these studies considered plantar pressure measurements in children. The purpose of the study was to investigate the effect of gender on foot pressure measurements in children. Methods: This is a comparative study using the F-Scan pressure platform (F-Mat; Texscan® Boston, MA) on a sample of children attending a podiatric clinic. Pressure measurements and temporal parameters were measured in 61 children between the ages of 5 and 16 years. Associations between joint hypermobility and hallux valgus angle also were investigated. Results: Girls were found to have significantly greater peak pressure under the hallux, faster timing of heel contact to first metatarsal head loading, and a more medially placed center of pressure trajectory. No associations were found between these significant variables and hypermobility scores or hallux valgus angle. Conclusion: The results indicate that there are differences in pressure measurements between boys and girls, but the reasons for these remain unclear. Differences in pressure measurements in the feet of boys and girls may be useful in establishing the cause of foot pathologies for which a prevalence has been shown in boys or girls, such as hallux valgus deformity, which is known to be more frequent in females of all ages.


    • 24 June 2005
      • Vol. 23  (3) , 413-20

    Joint hypermobility: the use of a new assessment tool to measure lower limb hypermobility.

    by J Ferrari, C Parslow, E Lim, A Hayward

    The aim of the study was to compare the use of a new assessment tool for diagnosis of hypermobility in the lower limb to the Beighton score for generalised hypermobility. Three groups of children were compared (n = 225) and included a "normal" population of 116 school children, a "possible hypermobile" group of 88 children attending afoot and gait clinic and a "known hypermobile" group of 21 children referred from a paediatrician or rheumatologist. The Beighton score was used to measure generalised hypermobility. The Lower Limb Assessment Score was used to measure hypermobility in the lower limbs. The Lower Limb Assessment Score was able to distinguish between the three groups of children better than the Beighton score. At a threshold of 5/9 indicating hypermobility, the Beighton score identified hypermobility in 34% of school children; the lower limb score identified hypermobility in 21% of school children after a threshold was identified. There was disagreement between the scores in school children where 26.7% of children appeared to have a positive Beighton score that was not accompanied by a positive lower limb score. In the "known hypermobile" group the Beighton score was positive in only 10% of children when the lower limb score was negative for hypermobility. In this group of school children, the Beighton score appeared to over-diagnose hypermobility at the threshold of 5/9. Specific thresholds for diagnosis need to be set dependant on the age and ethnic group of the population being studied. The Lower Limb Assessment Score may be a useful score for health professionals specifically interested in lower limb hypermobility.